Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
- Resource Type
- Article
- Authors
- Cunningham, Steve; Piedra, Pedra A; Verhulst, Stijn; Matthijs, Inge; Proesmans, Marijke; Goetghebuer, Tessa; Bosheva, Miroslava; Dosev, Svilen; Nikolova, Olga; Chakarova, Petranka; Wu Hupat, Elba; Mesa Monsalve, Juan; Turkalj, Mirjana; Mesaric Antoncic, Natasa; Tesovic, Goran; SIPL, Mirna; Kljaic Bukvic, Blazenka; Ivkovic-Jurekovic, Irena; Cicak, Biserka; Skalova, Sylva; Horneff, Gerd; Vogelberg, Christian; Gacs, Éva; Kalocsai, Krisztina; Madarasi, Anna; Kovacs, Lajos; Novak, Zoltan; Bene, Zsolt; Ashkenazi, Shai; Goldbart, Aviv; Bentur, Lea; Kolosa, Nadezda; Gardovska, Dace; Khaw, Poh Guan; Toh, Teck Hock; De Bruyne, Jessie Anne; Tan, Kah Kee; Alberto, Edison; Sablan, Benjamin, Junior; de Leon, Anjanette; Szymanski, Henryk; Repko, Miroslav; Kralinsky, Karol; Salamanca de la Cueva, Ignacio; Rodrigo Gonzalo de Liria, Carlos; Martinón-Torres, Federico; Cedena Romero, María Pilar; Monteagudo Montesinos, Emilio; Teeratakulpisarn, Jamaree; Puthanakit, Thanyawee; Oberdorfer, Peninnah; Warachit, Boonyarat; Brackeva, Benedicte; Dombrecht, Evelyne; Detalle, Laurent; Fleurinck, Carmen; Piedra, Pedro A; Martinon-Torres, Federico
- Source
- In The Lancet Respiratory Medicine January 2021 9(1):21-32
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600